Name: Apilimod
Text:
Apilimod (STA 5326) is a potent IL-12/IL-23 inhibitor, and strongly inhibits IL-12 in IFNg/SAC-stimulated human PBMCs and SAC-treated monkey PBMCs. Apilimod is a potent and highly selective PIKfyve inhibitor.
APILIMOD is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications.
Properties:safety: Irritant
smiles: CC1=CC(=CC=C1)/C=N/NC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4
formula: C23H26N6O2
chem_properties: Molecular Weight: 418.5 g/mol
XLogP3: 3.8
Hydrogen Bond Donor Count: 1
Hydrogen Bond Acceptor Count: 8
Rotatable Bond Count: 8
Exact Mass: 418.21172409 Da
Monoisotopic Mass: 418.21172409 Da
Topological Polar Surface Area: 84.8
Heavy Atom Count: 31
Formal Charge: 0
Complexity: 544
Isotope Atom Count: 0
Defined Atom Stereocenter Count: 0
Undefined Atom Stereocenter Count: 0
Defined Bond Stereocenter Count: 1
Undefined Bond Stereocenter Count: 0
Covalently-Bonded Unit Count: 1
Compound Is Canonicalized: Yes 

